Approval · Notice of Compliance 37072 · 2026
PRO-BICALUTAMIDE: Notice of Compliance 37072
Issued March 10, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37072
- Date
- March 10, 2026
- Company
- Pro Doc LimiteeLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Administrative: Licensing Agreement between two manufacturers. Administrative: Change in product name
- Canadian reference product
- CASODEX (Astrazeneca Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PRO-BICALUTAMIDE | 02311038 | Marketed |
Medicinal ingredients
- BICALUTAMIDE 50 MG per TAB